Clinical Trial Update: Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma

View source ↗

Summary

A real-world pharmacological monitoring study of the encorafenib and binimetinib combination for metastatic melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BRAFTOVI (ENCORAFENIB)
• MEKTOVI (BINIMETINIB)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Melanoma (Skin) | Status: RECRUITING